XOMA Royalty (XOMA) Competitors $24.77 -0.11 (-0.44%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$24.73 -0.04 (-0.16%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XOMA vs. XOMAO, MNKD, NVAX, INVA, OPK, GERN, ZBIO, MYGN, LXRX, and EBSShould you be buying XOMA Royalty stock or one of its competitors? The main competitors of XOMA Royalty include XOMA (XOMAO), MannKind (MNKD), Novavax (NVAX), Innoviva (INVA), OPKO Health (OPK), Geron (GERN), Zenas BioPharma (ZBIO), Myriad Genetics (MYGN), Lexicon Pharmaceuticals (LXRX), and Emergent Biosolutions (EBS). These companies are all part of the "medical" sector. XOMA Royalty vs. Its Competitors XOMA MannKind Novavax Innoviva OPKO Health Geron Zenas BioPharma Myriad Genetics Lexicon Pharmaceuticals Emergent Biosolutions XOMA Royalty (NASDAQ:XOMA) and XOMA (NASDAQ:XOMAO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Do analysts rate XOMA or XOMAO? XOMA Royalty currently has a consensus price target of $69.50, indicating a potential upside of 180.58%. Given XOMA Royalty's stronger consensus rating and higher possible upside, equities research analysts clearly believe XOMA Royalty is more favorable than XOMA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score XOMA Royalty 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00XOMA 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is XOMA or XOMAO more profitable? XOMA has a net margin of 0.00% compared to XOMA Royalty's net margin of -13.04%. XOMA's return on equity of 0.00% beat XOMA Royalty's return on equity.Company Net Margins Return on Equity Return on Assets XOMA Royalty-13.04% -12.43% -4.85% XOMA N/A N/A N/A Does the media refer more to XOMA or XOMAO? In the previous week, XOMA Royalty had 1 more articles in the media than XOMA. MarketBeat recorded 1 mentions for XOMA Royalty and 0 mentions for XOMA. XOMA Royalty's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score. Company Overall Sentiment XOMA Royalty Neutral XOMA Neutral Do insiders and institutionals believe in XOMA or XOMAO? 95.9% of XOMA Royalty shares are owned by institutional investors. 9.1% of XOMA Royalty shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, XOMA or XOMAO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXOMA Royalty$13.05M22.72-$13.82M-$1.15-21.54XOMA$13.05MN/AN/AN/AN/A SummaryXOMA Royalty beats XOMA on 6 of the 9 factors compared between the two stocks. Get XOMA Royalty News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XOMA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XOMA vs. The Competition Export to ExcelMetricXOMA RoyaltyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$297.74M$3.00B$5.47B$9.53BDividend YieldN/A2.43%4.74%4.08%P/E Ratio-21.5417.6228.6723.80Price / Sales22.72268.97422.2688.08Price / CashN/A41.9535.4557.96Price / Book3.568.508.275.55Net Income-$13.82M-$55.06M$3.24B$259.03M7 Day Performance-4.10%-3.98%-3.63%-4.56%1 Month Performance-5.13%9.59%4.40%4.49%1 Year Performance-0.48%6.72%25.97%18.05% XOMA Royalty Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XOMAXOMA Royalty3.9057 of 5 stars$24.77-0.4%$69.50+180.6%-3.9%$297.74M$13.05M-21.5410XOMAOXOMAN/A$25.53-0.4%N/A-1.0%$0.00$13.05M0.0010Positive NewsMNKDMannKind3.2911 of 5 stars$3.96-2.5%$9.86+148.9%-32.4%$1.23B$285.50M39.60400News CoverageUpcoming EarningsAnalyst DowngradeNVAXNovavax4.5925 of 5 stars$7.28-2.5%$15.86+117.8%-47.8%$1.21B$682.16M2.751,990News CoverageUpcoming EarningsGap DownINVAInnoviva4.1596 of 5 stars$18.54-1.0%$40.33+117.5%-3.4%$1.18B$358.71M-18.36100OPKOPKO Health4.0323 of 5 stars$1.35-1.5%$2.75+103.7%-13.5%$1.09B$713.10M-19.282,997News CoverageEarnings ReportGap DownGERNGeron2.9955 of 5 stars$1.15-8.7%$4.61+301.0%-75.5%$802.52M$76.99M-5.48229Upcoming EarningsHigh Trading VolumeZBIOZenas BioPharma1.6365 of 5 stars$16.45+5.0%$36.67+122.9%N/A$655.12M$5M-4.63N/APositive NewsMYGNMyriad Genetics4.2565 of 5 stars$4.38-1.6%$14.38+228.4%-85.8%$410.19M$837.60M-3.912,700News CoverageUpcoming EarningsGap DownLXRXLexicon Pharmaceuticals2.3898 of 5 stars$1.09-0.9%$3.67+236.4%-47.0%$397.64M$31.08M-2.14140News CoverageUpcoming EarningsEBSEmergent Biosolutions4.5434 of 5 stars$6.77-5.6%$14.33+111.7%-46.6%$389.17M$1.04B-2.502,420Upcoming EarningsGap Down Related Companies and Tools Related Companies XOMA Alternatives MannKind Alternatives Novavax Alternatives Innoviva Alternatives OPKO Health Alternatives Geron Alternatives Zenas BioPharma Alternatives Myriad Genetics Alternatives Lexicon Pharmaceuticals Alternatives Emergent Biosolutions Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XOMA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Royalty Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA Royalty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XOMA Stock Alerts